A Decade of Exploring the Cancer Epigenome - Biological and Translational Implications

Overview

Journal Nat Rev Cancer

Specialty Oncology

Date 2011 Sep 24

PMID 21941284

Citations 1430

Authors

Stephen B Baylin

Peter A Jones

Affiliations

Soon will be listed here.

Abstract

The past decade has highlighted the central role of epigenetic processes in cancer causation, progression and treatment. Next-generation sequencing is providing a window for visualizing the human epigenome and how it is altered in cancer. This view provides many surprises, including linking epigenetic abnormalities to mutations in genes that control DNA methylation, the packaging and the function of DNA in chromatin, and metabolism. Epigenetic alterations are leading candidates for the development of specific markers for cancer detection, diagnosis and prognosis. The enzymatic processes that control the epigenome present new opportunities for deriving therapeutic strategies designed to reverse transcriptional abnormalities that are inherent to the cancer epigenome.

Citing Articles

c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a.

Dong C, Sun Y, Xu X, Li H, Song X, Wei W Breast Cancer. 2025; .

PMID: 40029493 DOI: 10.1007/s12282-025-01683-w.

Novel Insights into PGM2L1 as a Prognostic Biomarker in Cholangiocarcinoma: Implications for Metabolic Reprogramming and Tumor Microenvironment Modulation.

Wu G, Hsieh Y, Chien Y, Bai L, Yu Y Int J Med Sci. 2025; 22(5):1158-1166.

PMID: 40027181 PMC: 11866533. DOI: 10.7150/ijms.106566.

Molecular insight into histone methylation as a novel target for oral squamous cell carcinoma: future hope in personalised medicine.

Rajendran P, Prasad M, Ali E, Sekar R, Alzahrani A, Karobari M J Cancer. 2025; 16(5):1575-1590.

PMID: 39991574 PMC: 11843246. DOI: 10.7150/jca.103243.

Energy metabolism in health and diseases.

Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.

PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.

Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.

Shou S, Maolan A, Zhang D, Jiang X, Liu F, Li Y Exp Hematol Oncol. 2025; 14(1):8.

PMID: 39871386 PMC: 11771031. DOI: 10.1186/s40164-025-00597-9.

References

Caligiuri M, Schichman S, Strout M, Mrozek K, Baer M, Frankel S . Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res. 1994; 54(2):370-3. View

Fenaux P, Mufti G, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A . Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 2009; 10(3):223-32. PMC: 4086808. DOI: 10.1016/S1470-2045(09)70003-8. View

Yamashita Y, Yuan J, Suetake I, Suzuki H, Ishikawa Y, Choi Y . Array-based genomic resequencing of human leukemia. Oncogene. 2010; 29(25):3723-31. DOI: 10.1038/onc.2010.117. View

Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield V . hDOT1L links histone methylation to leukemogenesis. Cell. 2005; 121(2):167-78. DOI: 10.1016/j.cell.2005.02.020. View

Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View

Wiegand K, Shah S, Al-Agha O, Zhao Y, Tse K, Zeng T . ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010; 363(16):1532-43. PMC: 2976679. DOI: 10.1056/NEJMoa1008433. View

Issa J . CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004; 4(12):988-93. DOI: 10.1038/nrc1507. View

Yap K, Li S, Munoz-Cabello A, Raguz S, Zeng L, Mujtaba S . Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38(5):662-74. PMC: 2886305. DOI: 10.1016/j.molcel.2010.03.021. View

Rideout 3rd W, Coetzee G, Olumi A, Jones P . 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science. 1990; 249(4974):1288-90. DOI: 10.1126/science.1697983. View

10.

Sakatani T, Kaneda A, Iacobuzio-Donahue C, Carter M, de Boom Witzel S, Okano H . Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science. 2005; 307(5717):1976-8. DOI: 10.1126/science.1108080. View

11.

Cedar H, Bergman Y . Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009; 10(5):295-304. DOI: 10.1038/nrg2540. View

12.

Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg A . Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature. 2008; 451(7175):202-6. PMC: 2743558. DOI: 10.1038/nature06468. View

13.

Jones P, Liang G . Rethinking how DNA methylation patterns are maintained. Nat Rev Genet. 2009; 10(11):805-11. PMC: 2848124. DOI: 10.1038/nrg2651. View

14.

Silverman L, Mufti G . Methylation inhibitor therapy in the treatment of myelodysplastic syndrome. Nat Clin Pract Oncol. 2005; 2 Suppl 1:S12-23. DOI: 10.1038/ncponc0347. View

15.

Jones P, Baylin S . The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3(6):415-28. DOI: 10.1038/nrg816. View

16.

Schwartz B, Hofer M, Lemieux M, Bauer D, Cameron M, West N . Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res. 2011; 71(7):2686-96. PMC: 3070805. DOI: 10.1158/0008-5472.CAN-10-3513. View

17.

Ohm J, Baylin S . Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation?. Cell Cycle. 2007; 6(9):1040-3. PMC: 2707146. DOI: 10.4161/cc.6.9.4210. View

18.

Bernstein B, Stamatoyannopoulos J, Costello J, Ren B, Milosavljevic A, Meissner A . The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol. 2010; 28(10):1045-8. PMC: 3607281. DOI: 10.1038/nbt1010-1045. View

19.

Kriaucionis S, Heintz N . The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. 2009; 324(5929):929-30. PMC: 3263819. DOI: 10.1126/science.1169786. View

20.

Schuebel K, Chen W, Cope L, Glockner S, Suzuki H, Yi J . Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 2007; 3(9):1709-23. PMC: 1988850. DOI: 10.1371/journal.pgen.0030157. View